Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 23

1.

Amyloid-β 11C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials.

Liu E, Schmidt ME, Margolin R, Sperling R, Koeppe R, Mason NS, Klunk WE, Mathis CA, Salloway S, Fox NC, Hill DL, Les AS, Collins P, Gregg KM, Di J, Lu Y, Tudor IC, Wyman BT, Booth K, Broome S, Yuen E, Grundman M, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators.

Neurology. 2015 Aug 25;85(8):692-700. doi: 10.1212/WNL.0000000000001877. Epub 2015 Jul 24.

2.

Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.

Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators.

N Engl J Med. 2014 Jan 23;370(4):322-33. doi: 10.1056/NEJMoa1304839.

3.

A syndrome of hereditary pancreatic adenocarcinoma and cysts of the liver and kidneys.

Gates LK Jr, Holladay DV.

Gastroenterology. 2002 Mar;122(3):796-9.

PMID:
11875013
4.

Prostate specific antigen bounce after radioactive seed implantation followed by external beam radiation for prostate cancer.

Critz FA, Williams WH, Benton JB, Levinson AK, Holladay CT, Holladay DA.

J Urol. 2000 Apr;163(4):1085-9.

PMID:
10737471
5.

Post-treatment PSA < or = 0.2 ng/mL defines disease freedom after radiotherapy for prostate cancer using modern techniques.

Critz FA, Williams WH, Holladay CT, Levinson AK, Benton JB, Holladay DA, Schnell FJ Jr, Maxa LS, Shrake PD.

Urology. 1999 Dec;54(6):968-71.

PMID:
10604691
6.

BRCA1-related and sporadic ovarian cancer in the same family: implications for genetic testing.

Richards WE, Gallion HH, Schmittschmitt JP, Holladay DV, Smith SA.

Gynecol Oncol. 1999 Dec;75(3):468-72.

PMID:
10600309
7.

Prostate specific antigen nadir achieved by men apparently cured of prostate cancer by radiotherapy.

Critz FA, Levinson AK, Williams WH, Holladay CT, Griffin VD, Holladay DA.

J Urol. 1999 Apr;161(4):1199-203; discussion 1203-5.

PMID:
10081869
8.

Simultaneous radiotherapy for prostate cancer: 125I prostate implant followed by external-beam radiation.

Critz FA, Levinson AK, Williams WH, Holladay CT, Griffin VD, Holladay DA.

Cancer J Sci Am. 1998 Nov-Dec;4(6):359-63.

PMID:
9853134
9.

Prostate-specific antigen nadir of 0.5 ng/mL or less defines disease freedom for surgically staged men irradiated for prostate cancer.

Critz FA, Levinson K, Williams WH, Holladay D, Holladay C, Griffin V.

Urology. 1997 May;49(5):668-72.

PMID:
9145968
10.

The PSA nadir that indicates potential cure after radiotherapy for prostate cancer.

Critz FA, Levinson AK, Williams WH, Holladay DA, Holladay CT.

Urology. 1997 Mar;49(3):322-6.

PMID:
9123692
11.

Prostate-specific antigen nadir: the optimum level after irradiation for prostate cancer.

Critz FA, Levinson AK, Williams WH, Holladay DA.

J Clin Oncol. 1996 Nov;14(11):2893-900.

PMID:
8918485
13.

Clinical presentation, treatment, and outcome of trilateral retinoblastoma.

Holladay DA, Holladay A, Montebello JF, Redmond KP.

Cancer. 1991 Feb 1;67(3):710-5. Review.

14.

Early detection of pregnancy-associated serum protein using antiserum to placental antigens.

Holladay DW, Caton JE, Ball FL, Holleman JW, Anderson NG.

Immunol Commun. 1976;5(1-2):1-11.

PMID:
59699
15.

Analytical techniques for cell fractions. XX. Cyclic affinity chromatography: principles and applications.

Anderson NG, Willis DD, Holladay DW, Caton JE, Holleman JW, Eveleigh JW, Attrill JE, Ball FL, Anderson NL.

Anal Biochem. 1975 Oct;68(2):371-93. No abstract available.

PMID:
812377
16.

Analytical techniques for cell fractions. XIX. The cyclum: an automatic system for cyclic chromatography.

Anderson NG, Willis DD, Holladay DW, Caton JE, Holleman JW, Eveleigh JW, Attrill JE, Ball FL, Anderson NL.

Anal Biochem. 1975 May 26;66(1):159-74. No abstract available.

PMID:
1147213
17.

Proceedings: Searching for human tumor antigens.

Anderson NG, Holladay DW, Caton JE, Candler EL, Dierlam PJ, Eveleigh JW, Bail FL, Holleman JW, Breillatt JP, Coggin JH Jr.

Cancer Res. 1974 Aug;34(8):2066-76. No abstract available.

18.

Purification of calf liver tRNA's.

Pearson RL, Weiss JF, Holladay DW, Kelmers AD.

Methods Enzymol. 1974;29:514-22. No abstract available.

PMID:
4853974
19.

Preparation of crude transfer RNA and chromatography purification of five transfer RNAs from calf liver.

Pearson RL, Hancher CW, Weiss JF, Holladay DW, Kelmers AD.

Biochim Biophys Acta. 1973 Jan 19;294(1):236-49. No abstract available.

PMID:
4736374
20.

Preparation of crude transfer RNA and chromatographic purification of five transfer RNAs from calf liver.

Pearson RL, Hancher CW, Weiss JF, Holladay DW, Kelmers AD.

Biochim Biophys Acta. 1973 Jan 19;294(2):236-49. No abstract available.

PMID:
4691883
Items per page

Supplemental Content

Loading ...
Write to the Help Desk